BACKGROUND: Chronic heart failure may increase risk of pneumonia due to alveoli flooding and reduced microbial clearance. We examined whether chronic heart failure is a risk factor for pneumonia-related hospitalization. METHODS: In this large population-based case-control study we identified adult patients with a first-time primary or secondary discharge diagnosis of viral or bacterial pneumonia between 1994 and 2008, using health care databases in Northern Denmark. For each case, ten sex- and age-matched population controls were selected from Denmark's Civil Registration System. We used conditional logistic regression to compute relative risk (RR) for pneumonia-related hospitalization among persons with and without pre-existing heart failure, overall and stratified by medical treatment. We controlled for a wide range of comorbidities, socioeconomic markers and immunosuppressive treatment. RESULTS: The study included 67,162 patients with a pneumonia-related hospitalization and 671,620 population controls. The adjusted OR for pneumonia-related hospitalization among persons with previous heart failure was 1.81 (95% confidence interval (CI): 1.76-1.86) compared with other individuals. The adjusted pneumonia RR was lower for heart failure patients treated with thiazides only (adjusted OR=1.56, 95% CI: 1.46-1.67), as compared with patients whose treatment included loop-diuretics and digoxin as a marker of increased severity (adjusted OR=1.95, 95% CI: 1.85-2.06) or both loop-diuretics and spironolactone (adjusted OR=2.02, 95% CI: 1.90-2.15). The population-attributable risk of pneumonia hospitalizations caused by heart failure in our population was 6.2%. CONCLUSIONS: Patients with chronic heart failure, in particular those using loop diuretics, have markedly increased risk of hospitalization with pneumonia.
BACKGROUND:Chronic heart failure may increase risk of pneumonia due to alveoli flooding and reduced microbial clearance. We examined whether chronic heart failure is a risk factor for pneumonia-related hospitalization. METHODS: In this large population-based case-control study we identified adult patients with a first-time primary or secondary discharge diagnosis of viral or bacterial pneumonia between 1994 and 2008, using health care databases in Northern Denmark. For each case, ten sex- and age-matched population controls were selected from Denmark's Civil Registration System. We used conditional logistic regression to compute relative risk (RR) for pneumonia-related hospitalization among persons with and without pre-existing heart failure, overall and stratified by medical treatment. We controlled for a wide range of comorbidities, socioeconomic markers and immunosuppressive treatment. RESULTS: The study included 67,162 patients with a pneumonia-related hospitalization and 671,620 population controls. The adjusted OR for pneumonia-related hospitalization among persons with previous heart failure was 1.81 (95% confidence interval (CI): 1.76-1.86) compared with other individuals. The adjusted pneumonia RR was lower for heart failurepatients treated with thiazides only (adjusted OR=1.56, 95% CI: 1.46-1.67), as compared with patients whose treatment included loop-diuretics and digoxin as a marker of increased severity (adjusted OR=1.95, 95% CI: 1.85-2.06) or both loop-diuretics and spironolactone (adjusted OR=2.02, 95% CI: 1.90-2.15). The population-attributable risk of pneumonia hospitalizations caused by heart failure in our population was 6.2%. CONCLUSIONS:Patients with chronic heart failure, in particular those using loop diuretics, have markedly increased risk of hospitalization with pneumonia.
Authors: Engi F Attia; Kathleen A McGinnis; Laura C Feemster; Kathleen M Akgün; Adeel A Butt; Christopher J Graber; Michael J Fine; Matthew B Goetz; Maria C Rodriguez-Barradas; Margaret A Pisani; Hilary A Tindle; Sheldon T Brown; Guy W Soo Hoo; David Rimland; Cynthia L Gibert; Laurence Huang; Matthew S Freiberg; Catherine L Hough; Kristina Crothers Journal: J Acquir Immune Defic Syndr Date: 2015-11-01 Impact factor: 3.731
Authors: Junichi Ishigami; Ron C Hoogeveen; Christie M Ballantyne; Aaron R Folsom; Josef Coresh; Elizabeth Selvin; Kunihiro Matsushita Journal: Am J Epidemiol Date: 2019-12-31 Impact factor: 4.897
Authors: Asako Kaneoka; Jessica M Pisegna; Haruhi Inokuchi; Rumi Ueha; Takao Goto; Takaharu Nito; Cara E Stepp; Michael P LaValley; Nobuhiko Haga; Susan E Langmore Journal: Dysphagia Date: 2017-09-02 Impact factor: 3.438
Authors: Lutz P Breitling; Kai-Uwe Saum; Ben Schöttker; Bernd Holleczek; Felix J Herth; Hermann Brenner Journal: Dtsch Arztebl Int Date: 2016-09-16 Impact factor: 5.594
Authors: Leonardo P Suciadi; Kevin Wibawa; Giovanni Jessica; Joshua Henrina; Irvan Cahyadi; Bryany T Santi; Titus K Hariadi; Firman Tedjasukmana; Nathania M Kristanti; Elisa F Pakpahan; Reynold A Manullang; Antono Sutandar Journal: Cureus Date: 2021-06-21
Authors: Marian Ryan; Jose A Suaya; John D Chapman; William B Stason; Donald S Shepard; Cindy Parks Thomas Journal: PLoS One Date: 2013-10-09 Impact factor: 3.240